Psychiatry Update 2022

Register now for our Psychiatry Update 2022 series, which includes 5 dates in the spring and fall! This free program is offered in a virtual format with up to 5 CME/CE credits.

Join fellow healthcare professionals from around the nation for this popular series, now in its 8th year! Join us online to hear from our world-class faculty as they discuss the latest diagnostic and therapeutic strategies in psychiatry today.


Tentative agenda

8:55 AM - 9:00 AM: Opening Remarks

9:00 AM - 10:00 AM: Identification and Management of Tardive Dyskinesia 2022
This session will offer practical tips for assessing tardive dyskinesia in patients with schizophrenia, mood spectrum disorders, and anxiety disorders, along with evidence-based treatment options, with a focus on VMAT2 inhibitors.

-15 min break-

10:15 AM - 11:15 AM: Non-CME Educational Talk
Sponsored by Intra-Cellular Therapies, Inc.
Clinical Evidence Supporting the Use of a Once-Daily Atypical Antipsychotic for Bipolar Depression: Bipolar I or II
Presenter: Adam Ashton, MD, MS, DLFAPA, Partner, Suburban Psychiatric Associates, Amherst, NY; Clinical Professor of Psychiatry, Jacobs School of Biomedical Sciences, Buffalo, NY

-15 min break-

11:30 AM - 12:30 PM: Managing Major Depression: Can We Do Better?
This session will review treatments for major depressive disorder with a focus on the use of atypical antipsychotics as augmentation therapy and insight into personalizing treatment plans for patients.

12:30 PM – 1:00 PM: Meal Break

1:00 PM - 2:00 PM: Non-CME Educational Talk
Sponsored by Neurocrine Biosciences, Inc.
Know the Difference to Make a Difference: Tardive Dyskinesia vs Drug-Induced Parkinsonism
Presenter: Stacy Cohen, MD, General and Addiction Psychiatrist CEO/Founder – The Moment Health Los Angeles, CA

-5 min break-

2:05 PM - 3:05 PM: Managing Bipolar Depression and Mixed Presentations
This session will explore the spectrum of bipolar disorders from diagnostic approaches to pharmacotherapies and will provide expert advice on sorting through mixed presentations of bipolar disorder to accurately diagnose and effectively treat patients.

-15 min break-

3:20 PM - 4:20 PM: What’s New in the Antipsychotic Treatment of Schizophrenia?
Medications for schizophrenia have traditionally focused on abating positive symptoms (ie, hallucinations, delusions), but there is a need for pharmacologic agents that address other domains of the disease, such as negative, motor, and cognitive symptoms. In this session, learners will gain knowledge of the mechanisms of action, efficacy, and tolerability/safety profiles of existing and emerging treatments to optimize patient outcomes in schizophrenia.

-5 min break-

4:25 PM - 5:25 PM: Recent Updates in ADHD: Optimizing Outcomes in a Digital World
Misconceptions of ADHD include that it is a childhood disease marked by hyperactivity and can be “grown out of.” These misconceptions consequently lead to underdiagnosis and undertreatment of adult and/or female patients with ADHD—creating a significant treatment gap. In this session, learn about factors influencing ADHD development and progression throughout the age spectrum, as well as clinical pearls for identification and management of various presentations of ADHD.

5:25 PM - 5:30 PM: Closing Remarks

*Note: All times are listed in local time for the location in which the meeting takes place. Please note that meals are not provided as part of the virtual simulcast and that onsite meetings include registration and breakfast beginning at 8:00 AM local time. Detailed agendas for each meeting are available on the Event Dates tab.


Date / Time
Event Details


Christoph U. Correll, MD

Professor of Psychiatry and Molecular Medicine
The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
New York, New York
Professor of Child and Adolescent Psychiatry
Charité – Universitätsmedizin Berlin
Berlin, Germany

Robert O. Cotes, MD

Associate Professor
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, Georgia

Charles DeBattista, DMH, MD

Chief, Depression Research Clinic
Director, Medical Student Education in Psychiatry
Professor of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Stanford, California

Manish Jha, MD

Assistant Professor
Center for Depression Research and Clinical Care
Department of Psychiatry
UT Southwestern Medical Center
Dallas, Texas

Vladimir Maletic, MD

Clinical Professor
Department of Psychiatry
USC School of Medicine
Greenville, South Carolina

Greg W. Mattingly, MD

Associate Clinical Professor
Washington University School of Medicine
St Louis, Missouri
St Charles Psychiatry Associates
St Charles, Missouri

Jonathan M. Meyer, MD

Voluntary Clinical Professor, Department of Psychiatry
University of California, San Diego
Psychopharmacology Consultant
Balboa Naval Medical Center First Episode Psychosis Program
State of Nevada Project ECHO First Episode Psychosis Program


Medical Director, Rochester Center for Behavioral Medicine
Rochester Hills, Michigan
Clinical Associate Professor of Psychiatry
Wayne State University School of Medicine
Detroit, Michigan

Program Overview
The primary purpose of this activity is to improve participants’ competence in addressing the most important and most current challenges in the treatment of psychiatric illness by providing a focused update on recent advances and key issues.

Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners to assess diagnostic considerations and new and emerging therapies for the treatment of psychiatric illness.

Target Audience 
This activity is intended for physicians, physician assistants, nurse practitioners, registered nurses, pharmacists, social workers, and psychologists engaged in the care of patients with psychiatric illness.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Review and assess the latest advances in treatment options for your patients with ADHD, major depression, bipolar depression and mixed presentations, schizophrenia, and tardive dyskinesia
  • Develop individualized treatment strategies for optimal outcomes in your patients with complex psychiatric disorders
  • Discuss best practices to improve patient care


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 5.0 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 5.0 contact hours (0.5 CEUs) of the Accreditation Council for Pharmacy Education. UAN: UAN will be specific to each topic

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Assistant Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity offers 5.0 continuing education credits for psychologists

Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC (CCO) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. CCO maintains responsibility for this course. Social workers completing this course receive 5.0 continuing education credits.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.